Tuesday, January 21, 2025 9:10:58 PM
Why would any BP support NWBO when they are teetering on the verge of bankruptcy? NWBO is going to die on the vine. How many more years before a legitimate regulatory approval? I can't even believe they are dangling the combo trials and direct resurrection......where is that money going to come from (most definitely not from the UK)? They need to focus on generating revenue aka ramping up commercialization. NWBO seriously needs to stop gaslighting investors with these ridiculous carrots. Until then continous non-stop dilution...can we say 2B plus share authorized incoming?
Didn't you get the Memo.....MM/BP are stopping this crew from executing in a timely fashion. LMFAO. 6 years since this trial ended, 4.5 years since data lock, and 20 year from trial inception....and they ain't got a regulatory approval STILL. That isn't how normal pre-rev bios work....no matter how many times the pump crew says it is. This gotta be the guinness book of world record for slowest time to regulatory approval hands down. They accomplished their main goal of building up a CDMO for LP. Gotta at least put up the front that they are trying to gain approval......
Didn't you get the Memo.....MM/BP are stopping this crew from executing in a timely fashion. LMFAO. 6 years since this trial ended, 4.5 years since data lock, and 20 year from trial inception....and they ain't got a regulatory approval STILL. That isn't how normal pre-rev bios work....no matter how many times the pump crew says it is. This gotta be the guinness book of world record for slowest time to regulatory approval hands down. They accomplished their main goal of building up a CDMO for LP. Gotta at least put up the front that they are trying to gain approval......
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
